A new trading day began on Friday, with Relay Therapeutics Inc (NASDAQ: RLAY) stock price down -8.84% from the previous day of trading, before settling in for the closing price of $5.60. RLAY’s price has ranged from $5.59 to $12.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 319.82%. Meanwhile, its annual earnings per share averaged 8.22%. With a float of $121.92 million, this company’s outstanding shares have now reached $127.46 million.
The extent of productivity of a business whose workforce counts for 323 workers is very important to gauge. In terms of profitability, gross margin is 58.64%, operating margin of -3926.55%, and the pretax margin is -3449.92%.
Relay Therapeutics Inc (RLAY) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Relay Therapeutics Inc is 25.72%, while institutional ownership is 73.10%. The most recent insider transaction that took place on Oct 28 ’24, was worth 9,823. In this transaction an insider of this company sold 1,621 shares at a rate of $6.06, taking the stock ownership to the 390,063 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Chief Financial Officer sold 6,802 for $6.06, making the entire transaction worth $41,220. This insider now owns 306,391 shares in total.
Relay Therapeutics Inc (RLAY) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.67 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.22% per share during the next fiscal year.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Here are Relay Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 18.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 77.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.61 in the next quarter and is forecasted to reach -2.64 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
The latest stats from [Relay Therapeutics Inc, RLAY] show that its last 5-days average volume of 1.3 million was inferior to 1.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 8.96%. Additionally, its Average True Range was 0.39.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 1.32%, which indicates a significant decrease from 5.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.98% in the past 14 days, which was lower than the 93.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.71, while its 200-day Moving Average is $7.41. Now, the first resistance to watch is $5.48. This is followed by the second major resistance level at $5.86. The third major resistance level sits at $6.08. If the price goes on to break the first support level at $4.88, it is likely to go to the next support level at $4.66. The third support level lies at $4.28 if the price breaches the second support level.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
With a market capitalization of 778.96 million, the company has a total of 167,383K Shares Outstanding. Currently, annual sales are 25,550 K while annual income is -341,970 K. The company’s previous quarter sales were 0 K while its latest quarter income was -92,210 K.
